Public Comment Information for the May 11, 2018 Joint Meeting of the Pediatric and Endocrinologic and Metabolic Drugs Advisory Committees
10000 New Hampshire Avenue
Silver Spring, Maryland 20903
May 11, 2018
PUBLIC COMMENTS RECEIVED
(Docket No. FDA-2018-N-0045)
A federal docket (Docket No. FDA-2018-N-0045) was opened to provide the public the opportunity to provide their written comments and opinions in relation to the meeting topic of March 22, 2018 Joint Meeting of the PAC and EMDAC. Since the meeting was postponed on March 22, 2018, comments submitted to the docket are included as part of the background materials for the May 11, 2018 meeting.
Below is a link to the comments received to the public docket